卵巢功能丧失和雌激素治疗重塑大脑的突触和代谢蛋白质组
Sebastian F Salathe1, Edziu Franczak1, Zane Busick1
1Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City KS, USA.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
雌激素疗法 (E2) 通过保存对突触功能和新陈代谢至关重要的蛋白质,有助于在更年期期间保持大脑健康. E2治疗还可以防止与卵巢激素损失相关的线粒体能量生产下降.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 代谢学 代谢学 代谢学
背景情况:
- 更年期与认知能力下降和大脑新陈代谢减少有关.
- 雌激素 (E2) 治疗可以减轻这些更年期影响.
- 了解雌激素神经保护的分子机制对于女性的大脑健康至关重要.
研究的目的:
- 研究卵巢激素损失和E2治疗对老年雌性小鼠大脑蛋白质组和线粒体功能的影响.
- 为了确定受更年期和E2治疗影响的特定蛋白质和代谢途径.
主要方法:
- 年龄较大的雌性C57BL/6J小鼠接受了假或卵巢切除 (OVX) 手术.
- 在OVX小鼠中,小鼠被食高脂肪饮食,然后接受E2或载体治疗.
- 进行了大脑同质体的蛋白质组分析和线粒体呼吸和酶活性的评估.
主要成果:
- E2 调节了 4,992 种蛋白质,增强了突触生成信号.
- OVX减少了参与突触功能,新陈代谢 (氨基酸,,TCA循环) 和氧化酸化 (OxPhos) 的蛋白质.
- 取代E2恢复了这些通路中的蛋白质表达,改善了复杂IV活性,但没有改变基底/状态3呼吸.
结论:
- 雌激素 (E2) 通过维护突触完整性和代谢蛋白质,对维持大脑健康至关重要.
- E2减轻了与更年期相关的线粒体生物能量的下降.
- 这些发现支持E2疗法作为一种策略,以维持经更年期妇女的认知功能和大脑代谢.
更多相关视频
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.8K
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
16.0K
相关概念视频
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Oogenesis
68.9K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.9K
Hormonal Control of the Ovarian Cycle
6.4K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.4K
Hormonal Regulation of the Menstrual Cycle
1.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
Neurotransmitters
2.6K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
2.6K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
